Bruker (BRKR) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.39% |
| Dec 31, 2025 | 7.49% |
| Sep 30, 2025 | 8.85% |
| Jun 30, 2025 | 13.96% |
| Mar 31, 2025 | 15.26% |
| Dec 31, 2024 | 10.73% |
| Sep 30, 2024 | 10.53% |
| Jun 30, 2024 | 10.79% |
| Mar 31, 2024 | 10.44% |
| Dec 31, 2023 | 9.54% |
| Sep 30, 2023 | 11.45% |
| Jun 30, 2023 | 10.66% |
| Mar 31, 2023 | 12.52% |
| Dec 31, 2022 | 7.39% |
| Sep 30, 2022 | 11.01% |
| Jun 30, 2022 | 10.08% |
| Mar 31, 2022 | 11.67% |
| Dec 31, 2021 | 9.16% |
| Sep 30, 2021 | 10.76% |
| Jun 30, 2021 | 10.53% |
| Mar 31, 2021 | 10.81% |
| Dec 31, 2020 | 8.16% |
| Sep 30, 2020 | 8.19% |
| Jun 30, 2020 | 1.91% |
| Mar 31, 2020 | 3.72% |
| Dec 31, 2019 | 6.55% |
| Sep 30, 2019 | 8.70% |
| Jun 30, 2019 | 2.82% |
| Mar 31, 2019 | 3.62% |
| Dec 31, 2018 | 2.95% |
| Sep 30, 2018 | 2.87% |
| Jun 30, 2018 | 0.35% |
| Mar 31, 2018 | 2.70% |
| Dec 31, 2017 | 1.17% |
| Sep 30, 2017 | -1.09% |
| Jun 30, 2017 | -0.34% |
| Mar 31, 2017 | -1.46% |
| Dec 31, 2016 | 0.25% |
| Sep 30, 2016 | -0.45% |
| Jun 30, 2016 | -1.52% |
| Mar 31, 2016 | 0.61% |
| Dec 31, 2015 | 1.52% |
| Sep 30, 2015 | 2.72% |
| Jun 30, 2015 | 4.60% |
| Mar 31, 2015 | 4.90% |